CARISMA Therapeutics names new CFO
9 June 2021 -

CARISMA Therapeutics Inc, a clinical stage biopharmaceutical company, announced on Tuesday that it has named Richard Morris as its new chief financial officer.

Morris has over 25 years of experience in building and growing biotech organisations. He has served as CFO at Passage Bio. He has also held the position of executive vice president and CFO for Context Therapeutics and CFO for Vitae Pharmaceuticals. He has held various senior financial roles at ViroPharma and has served at the healthcare assurance practice at KPMG.

Morris earned a Bachelor of Science in accounting at Saint Joseph's University in Philadelphia, PA and is a certified public accountant.